Task order: evaluation of two different classes of compounds (STAT3 inhibitors and serms) for the prevention of urinary bladder cancer
Ended Awarded Last action
- Contract number
- 75N91019F00130
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $135,660
Award facts
- Opportunity
- Contract value 100% obligated
- $135,660.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$479,421 | |
| Original award | $615,081 |
About this award
The University of Alabama at Birmingham was awarded a $135,660 firm fixed price delivery order against the PREVENT Preclinical Drug Development Program master IDIQ contract by the National Cancer Institute. The task order calls for the evaluation of two classes of compounds, STAT3 inhibitors and SERMs, for the prevention of urinary bladder cancer. This work will be performed under the PREVENT Efficacy Pool, part of the National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program aimed at advancing promising cancer prevention agents into clinical trials. Work will take place in Birmingham, Alabama over a seven-month period concluding in April 2020.
Quick answers
Who was awarded contract 75N91019F00130?
75N91019F00130 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 15, 2019.
How much is contract 75N91019F00130 worth?
The government has obligated $135,660 on 75N91019F00130.
Is contract 75N91019F00130 an order under another contract?
Yes. 75N91019F00130 is a delivery order under 75N91019D00019, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91019F00130 competed?
The extent of competition for 75N91019F00130 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award